ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,247.79
-0.41%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,314.575
-0.26%
Brent Oil
84.345
0.19%
Bitcoin
62,080.61
0.45%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) News

Compugen (CGEN)

Compugen Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CGEN
DateTimeSourceHeadlineSymbolCompany
17/06/202412:00PR Newswire (US)Compugen to Present at Upcoming Antibody Industrial SymposiumNASDAQ:CGENCompugen Ltd
30/05/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
30/05/202412:00PR Newswire (US)Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating RilvegostomigNASDAQ:CGENCompugen Ltd
20/05/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
20/05/202412:00PR Newswire (US)Compugen Reports First Quarter 2024 ResultsNASDAQ:CGENCompugen Ltd
20/05/202411:59IH Market NewsU.S. Index Futures Edge Slightly Higher in Pre-Market Trading, Oil Prices DipNASDAQ:CGENCompugen Ltd
16/05/202412:00PR Newswire (US)Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic PotentialNASDAQ:CGENCompugen Ltd
15/05/202412:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
15/05/202412:00PR Newswire (US)Compugen Appoints David Silberman as Chief Financial OfficerNASDAQ:CGENCompugen Ltd
06/05/202412:00PR Newswire (US)Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024NASDAQ:CGENCompugen Ltd
25/04/202412:00PR Newswire (US)Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024NASDAQ:CGENCompugen Ltd
10/04/202412:00PR Newswire (US)Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503NASDAQ:CGENCompugen Ltd
03/04/202412:00PR Newswire (US)Compugen to Participate in Two Upcoming Investor ConferencesNASDAQ:CGENCompugen Ltd
11/03/202411:00PR Newswire (US)Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer ImmunotherapyNASDAQ:CGENCompugen Ltd
06/03/202412:00PR Newswire (US)Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024NASDAQ:CGENCompugen Ltd
05/03/202421:06Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:CGENCompugen Ltd
05/03/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
05/03/202412:00PR Newswire (US)Compugen Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:CGENCompugen Ltd
05/03/202411:05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:CGENCompugen Ltd
26/02/202412:00PR Newswire (US)Compugen to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:CGENCompugen Ltd
20/02/202412:00PR Newswire (US)Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024NASDAQ:CGENCompugen Ltd
15/02/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
15/02/202412:00PR Newswire (US)Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical OfficerNASDAQ:CGENCompugen Ltd
08/01/202412:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
08/01/202412:05PR Newswire (US)Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract CancerNASDAQ:CGENCompugen Ltd
08/01/202412:00PR Newswire (US)Compugen Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:CGENCompugen Ltd
19/12/202314:30AllPennyStocks.comStrong Open For Biotech Following Exclusive Agreement AnnouncementNASDAQ:CGENCompugen Ltd
19/12/202312:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
19/12/202312:10PR Newswire (US)Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract CancerNASDAQ:CGENCompugen Ltd
19/12/202312:05PR Newswire (US)Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 BiologyNASDAQ:CGENCompugen Ltd
 Showing the most relevant articles for your search:NASDAQ:CGEN

Your Recent History

USOTC
SRCH
Searchlight Minerals (PK)
BIT
UV8BM3
UniCredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved